2nd Annual RIPL Symposium Examines IP Issues in Biotechnology

The Review of Intellectual Property Law at The John Marshall Law School is presenting its 2nd annual symposium, “Biotechnology and Health-Related Issues in IP Law,” from 8 a.m. to 5 p.m. Friday, April 15, at the law school.

Speakers will discuss various topics, including covering the 1,000 Genomes Project; intellectual property (IP) protection and HIV/AIDS governance; TRIPS in public health; biomarker-based inventions, and regulatory concerns on biopesticides and intragenic inventions.

The keynote speaker at noon will be Dr. Ananda M. Chakrabarty, distinguished professor at the University of Illinois College of Medicine. He is the founder of CDG Therapeutics and co-founder of Amrita Therapeutics Ltd.Presenters throughout the day will be Katherine Addison, an IP and patent attorney; Alberto Alemanno, professor, HEC Paris, and adjunct professor at Georgetown Law; Enrico Bonadio, lecturer in IP law at City University London; and Dr. Saby Ghoshray, president of the Institute of Interdisciplinary Studies at the University of Amsterdam. Also, Donna M.  Gitter, associate professor, Baruch College, City University of New York; Brian J. Gorman, assistant professor, Towson University, and director of Biosecurity Commons; Vid S. Mohan-Ram, associate at Foley & Lardner LLP; Lawrence S. Pope, patent attorney; and Peter Yu, professor and Kern Family Chair in Intellectual Property Law at Drake University Law School.

The program is free to John Marshall students and faculty. Registrations are being accepted by the Office of Event Management at www.jmls.edu/RIPL2011.

Leave a Reply

Cookie Settings